Clinical Trial Update: Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immune response and safety of GlaxoSmithKline's Mencevax ACWY meningococcal vaccine in subjects previously primed in the DTPW-HBV=HIB-M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• Mencevax ACWY

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2017-08-03